- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 16, 2025 | 41.55M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $3M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $19.56M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $25.74M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $26.45M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $33.19M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $35.1M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $43.62M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $46.35M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $54.89M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 40M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $104.43K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$636.99K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $18.14M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $14.49M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.11M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $162.25K |
| Net Income | Q1 2025 · Mar 31, 2024 | $3.18M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $3.97M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $10.45M |
| Revenue | Q1 2025 · Mar 31, 2024 | $30.15M |